Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MYO

Myomo Inc

May 10 • 04:00PM ET

3.83

Dollar change +0.27
Percentage change 7.58	%

Healthcare • Medical Devices • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.27	Insider Own	22.65%	Shs Outstand	27.14M	Perf Week	1.86%
Market Cap	110.34M	Forward P/E	-	EPS next Y	-0.06	Insider Trans	1.56%	Shs Float	22.29M	Perf Month	22.76%
Income	-9.34M	PEG	-	EPS next Q	-0.09	Inst Own	37.93%	Short Float	2.84%	Perf Quarter	4.08%
Sales	19.55M	P/S	5.64	EPS this Y	15.18%	Inst Trans	-0.50%	Short Ratio	2.24	Perf Half Y	102.65%
Book/sh	0.38	P/B	10.12	EPS next Y	74.74%	ROA	-61.73%	Short Interest	0.63M	Perf Year	650.98%
Cash/sh	0.38	P/C	10.07	EPS next 5Y	-0.47%	ROE	-90.97%	52W Range	0.37 - 5.58	Perf YTD	-23.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	59.45%	ROI	-85.18%	52W High	-31.36%	Beta	1.46
Dividend TTM	-	Quick Ratio	2.40	Sales past 5Y	54.66%	Gross Margin	67.39%	52W Low	932.35%	ATR (14)	0.34
Dividend Ex-Date	-	Current Ratio	2.83	EPS Y/Y TTM	78.12%	Oper. Margin	-48.34%	RSI (14)	56.98	Volatility	12.97% 10.02%
Employees	106	Debt/Eq	0.04	Sales Y/Y TTM	29.17%	Profit Margin	-47.77%	Recom	1.00	Target Price	6.44
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	4.48%	Payout	-	Rel Volume	1.16	Prev Close	3.56
Sales Surprise	-7.77%	EPS Surprise	-3.41%	Sales Q/Q	8.93%	Earnings	May 08 AMC	Avg Volume	283.14K	Price	3.83
SMA20	13.75%	SMA50	12.79%	SMA200	45.92%	Trades		Volume	329,396	Change	7.58%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-15-23	Initiated	H.C. Wainwright	Buy	$6.50
Nov-11-20	Upgrade	ROTH Capital	Neutral → Buy	$5 → $7
May-27-20	Initiated	Dougherty & Company	Buy	$8.50
Oct-02-17	Initiated	H.C. Wainwright	Buy	$12

May-10-24 04:03PM	Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges (GuruFocus.com) +7.58%
01:01PM	Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... (GuruFocus.com)
May-09-24 01:16PM	Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.41%
May-08-24 04:05PM	Myomo Reports First Quarter 2024 Financial Results (Business Wire) +8.56%
May-06-24 01:19PM	Myomo Receives Reimbursements For MyoPros from CMS (MT Newswires)
08:30AM	Loading…
08:30AM	Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees (Business Wire)
May-01-24 05:21PM	Myomo to Report First Quarter Financial Results on May 8, 2024 (Business Wire) +7.95%
Mar-28-24 04:05PM	Myomo Appoints Heather Getz to its Board of Directors (Business Wire) -6.57%
Mar-18-24 11:00AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
Mar-08-24 10:15AM	Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.38%
Mar-07-24 06:00PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-01-24 08:00AM	CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® (Business Wire) +31.05%
Feb-29-24 04:05PM	Myomo to Report Fourth Quarter Financial Results on March 7, 2024 (Business Wire)
Jan-19-24 04:05PM	Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire)
08:05AM	Loading…
Jan-17-24 08:05AM	Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) +7.89%
08:00AM	Myomo Reports Preliminary Fourth Quarter Revenue and Backlog (Business Wire)
Dec-20-23 08:50AM	What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing' (Zacks) -19.21%
Dec-12-23 07:00AM	7 Stock Winners That Are Up 1,000% or More in 2023 (InvestorPlace)
Dec-01-23 10:00AM	Top Penny Stocks for Q4 2023 (Investopedia) +7.42%
Nov-20-23 04:16PM	3 Hot Penny Stocks to Buy in Q4 for Promising Potential (InvestorPlace) +5.88%
Nov-08-23 11:47AM	Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.39%
Nov-07-23 04:05PM	Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations (Business Wire) +6.02%
Nov-06-23 08:30AM	CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting (Business Wire) +21.17%
Nov-02-23 10:08AM	Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category (Business Wire) +8.00%
Oct-31-23 04:05PM	Myomo to Report Third Quarter Financial Results on November 7, 2023 (Business Wire)
Aug-29-23 04:05PM	Myomo Announces Closing of $4.4 Million Public Offering (Business Wire)
Aug-28-23 12:38PM	Is Myomo (MYO) a Hidden Gem or a Value Trap? A Comprehensive Analysis (GuruFocus.com) +18.69%
Aug-25-23 07:00AM	Myomo Announces Pricing of $4.4 Million Public Offering (Business Wire) -10.13%
Aug-24-23 07:33PM	Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap? (GuruFocus.com) +18.82%
04:15PM	Loading…
04:15PM	Myomo, Inc. Announces Proposed Public Offering (Business Wire)
04:05PM	Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims (Business Wire)
Aug-21-23 04:05PM	Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement (Business Wire) +10.80%
Aug-09-23 05:30PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.00%
04:05PM	Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics (Business Wire)
Aug-02-23 04:05PM	Myomo to Report Second Quarter Financial Results on August 9, 2023 (Business Wire)
Jul-05-23 10:50AM	Myomo's (MYO) MyoPro Seeks CMS Classification for Medicare Cover (Zacks)
Jul-03-23 08:30AM	Centers for Medicare and Medicaid Services Accepts Myomos Application to Classify the MyoPro® as a Brace (Business Wire) +19.31%
Jun-14-23 04:05PM	Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest (Business Wire)
May-22-23 09:55AM	Here's Why Myomo, Inc. (MYO) Is a Great 'Buy the Bottom' Stock Now (Zacks)
May-10-23 06:05PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-23 07:05PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-23 07:45AM	Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-03-23 04:05PM	Myomo to Report First Quarter Financial Results on May 10, 2023 (Business Wire) -7.69%
Apr-10-23 08:30AM	Myomo Receives Technology License Fee Payment from China Joint Venture Company (Business Wire) +5.22%
Mar-16-23 05:30AM	SVB Collapse Spurs Finance Executives to Re-Evaluate Cash Strategies (The Wall Street Journal)
Mar-15-23 08:30AM	Myomo Makes NYSE American Section 610(b) Public Announcement (Business Wire)
Mar-14-23 11:11AM	Myomo, Inc. (AMEX:MYO) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.84%
Mar-13-23 09:45AM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Myomo Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Mar-07-23 10:12AM	Myomo to Report Fourth Quarter Financial Results on March 13, 2023 (Business Wire)
Mar-06-23 04:05PM	Myomo To Participate in the 35th Annual Roth Conference (Business Wire) +11.26%
Feb-06-23 04:05PM	MyoPro Approved in Australia by National Disability Insurance Scheme (Business Wire)
Feb-01-23 04:25PM	7 Top Short-Squeeze Candidates to Watch in February (InvestorPlace)
Jan-30-23 04:05PM	Myomo Appoints Yitzchak Jacobovitz to its Board of Directors (Business Wire)
Jan-17-23 04:05PM	Myomo Announces Closing of $6.5 Million Upsized Public Offering (Business Wire)
Jan-12-23 08:30AM	Myomo Announces Pricing of $6.5 Million Upsized Public Offering (Business Wire) -14.99%
Jan-10-23 04:17PM	Myomo Announces Initiative to Reduce Cash Burn (Business Wire)
Dec-07-22 05:00PM	Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro (Business Wire)
Dec-05-22 08:30AM	Ruling by German Social Court Supports MyoPro Reimbursement by Nations Statutory Health Insurance System (Business Wire)
Nov-21-22 03:04PM	10 Best Robotic Stocks Under $10 (Insider Monkey) -18.64%
Nov-10-22 05:55PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog (Business Wire)
Nov-09-22 05:25PM	NuVasive (NUVA) Surpasses Q3 Earnings Estimates (Zacks)
Nov-03-22 04:05PM	Myomo to Report Third Quarter Financial Results on November 10, 2022 (Business Wire)
Oct-05-22 04:30PM	Myomo To Present at the MicroCap Rodeo Presents The Windy City Roundup 2022 (ACCESSWIRE)
Sep-07-22 08:30AM	Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference (Business Wire)
Aug-30-22 08:30AM	Myomo Receives Order from the Louis Stokes Cleveland VA Medical Center to Support MyoPro Clinical Trial (Business Wire)
Aug-03-22 06:35PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +13.81%
04:05PM	Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions (Business Wire)
Jul-28-22 10:03AM	Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-27-22 04:15PM	Myomo to Report Second Quarter Financial Results on August 3, 2022 (Business Wire)
10:04AM	Stryker's (SYK) Q2 Earnings and Revenues Miss Estimates (Zacks)
Jul-18-22 12:00PM	What Makes Myomo, Inc. (MYO) a New Strong Buy Stock (Zacks)
Jul-07-22 04:05PM	Myomo Announces Second Quarter Preliminary Revenue and Record Pipeline Additions (Business Wire)
Jun-14-22 02:45PM	Sidoti's Summer Small Cap Virtual Conference (ACCESSWIRE)
Jun-09-22 04:05PM	Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference (Business Wire)
May-25-22 10:34AM	11 Best Robotics Stocks Under $10 (Insider Monkey)
May-11-22 06:05PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports First Quarter 2022 Financial Results (Business Wire)
May-04-22 04:15PM	Myomo to Report First Quarter Financial Results on May 11, 2022 (Business Wire)
Apr-04-22 04:15PM	Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee (Business Wire)
Mar-09-22 05:35PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Myomo To Participate in Two March Investor Conferences (Business Wire)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2021 Financial Results (Business Wire)
Mar-02-22 04:15PM	Myomo to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022 (Business Wire)
Feb-17-22 04:15PM	Myomo Strengthens Intellectual Property Portfolio With Receipt of Key Patent in Japan (Business Wire)
Feb-14-22 08:30AM	Independent Research with Myomos MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness (Business Wire)
Jan-18-22 07:30AM	Sidoti Winter Virtual Small Cap Investor Conference (ACCESSWIRE)
Jan-13-22 04:30PM	Myomo to Present at the Sidoti Winter Small Cap Conference (Business Wire)
Jan-10-22 08:30AM	Myomo Provides Update on MyoPro® Insurance Reimbursement (Business Wire) +9.96%
Jan-06-22 04:05PM	Myomo Announces MyoPro® 2+ (Business Wire)
Jan-05-22 04:05PM	Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement (Business Wire)
Nov-10-21 06:25PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Third Quarter 2021 Financial Results Feature Record Revenue (Business Wire)
Nov-03-21 04:05PM	Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021 (Business Wire)
Nov-02-21 03:02PM	Will Myomo, Inc. (MYO) Report Negative Q3 Earnings? What You Should Know (Zacks)
Oct-15-21 09:15AM	Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants (Business Wire)
Oct-04-21 04:30PM	36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 (ACCESSWIRE)
Sep-28-21 04:30PM	Myomo, Inc. to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5th (ACCESSWIRE)

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KIRK THOMAS F	Director	Mar 14 '24	Buy	3.50	50,000	175,000	186,499	Mar 18 07:48 AM
KIRK THOMAS F	Director	Nov 20 '23	Buy	3.10	50,000	155,000	136,499	Dec 14 07:46 PM
Morris Milton Mayo	Director	Sep 08 '23	Buy	1.06	15,000	15,867	77,933	Sep 11 05:05 PM
GUDONIS PAUL R	Chief Executive Officer	Aug 30 '23	Buy	0.74	48,400	36,039	878,245	Aug 31 06:26 PM
GUDONIS PAUL R	Chief Executive Officer	Aug 29 '23	Buy	0.78	37,000	28,797	829,845	Aug 30 04:22 PM
HENRY DAVID A	Chief Financial Officer	Aug 29 '23	Buy	0.60	41,666	25,000	352,193	Aug 30 04:36 PM
Kovelman Harry	Chief Medical Officer	Aug 29 '23	Buy	0.60	8,333	5,000	149,556	Aug 30 05:00 PM
GUDONIS PAUL R	Chief Executive Officer	Aug 28 '23	Buy	0.75	42,500	31,794	792,845	Aug 30 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MYO

Myomo Inc

Upgrade your FINVIZ experience